Skip to content
2000
Volume 22, Issue 3
  • ISSN: 1573-4072
  • E-ISSN: 1875-6646

Abstract

The neglected tropical disease (NTD), trachoma comprises the infection of eye produced by a pathogenic bacteria known as a sexually transmitted bacterium that leads to ocular infection which ultimately leads to ocular destruction or complete blindness. Around 80-85 million individuals worldwide are infected wherein 60-90 percent of the said infection is detected only in youngsters in several places. Trachoma considerably prevails in rural areas where sanitation and healthcare are the major issues and these are the world’s low-income countries. The epidemiology of the said disease is complex and related to the environmental conditions. This review article focused on the pathophysiology of trachoma and the use of phytochemicals from herbal sources. Herbal remedies are the best way to manage any disease as they are comparatively safer and have fewer side effects. Although there are various conventional treatments including the use of antibiotics like erythromycin, sulphonamides, and azithromycin for the management of said diseases. They have various adverse effects including, abdominal pain, vomiting, and over usage can even lead to permanent blindness. Thus, to avoid these adverse effects the scientific community focused on herbal therapeutics and their secondary metabolites that have a major role in the designing and development of safer therapeutics. This review focused on the isoquinoline alkaloids obtained from medicinal plants that can be used in the development of the newer pharmacophore for the management of trachoma.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cbc/10.2174/0115734072351741250318232624
2025-04-04
2026-03-08

  • From This Site

    /content/journals/cbc/10.2174/0115734072351741250318232624
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. CheukaP.M. MayokaG. MutaiP. ChibaleK. The role of natural products in drug discovery and development against neglected tropical diseases.Molecules201722158
     [Google Scholar]
  2. BallweberL.M. JaynesJ.E. StammW.E. LampeM.F. In vitro microbicidal activities of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatis.Antimicrob. Agents Chemother.2002461344110.1128/AAC.46.1.34‑41.2002 11751108
     [Google Scholar]
  3. TaylorH.R. Doyne Lecture: Trachoma, is it history?Eye200923112007202210.1038/eye.2008.432 19265868
     [Google Scholar]
  4. BurtonM.J. Trachoma: An overview.Br. Med. Bull.20078419911610.1093/bmb/ldm034 18175788
     [Google Scholar]
  5. JosephS.J. DidelotX. RothschildJ. de VriesH.J.C. MorréS.A. ReadT.D. DeanD. Population genomics of Chlamydia trachomatis: In ghts on drift, selection, recombination, and population structure.Mol. Biol. Evol.201229123933394610.1093/molbev/mss198 22891032
     [Google Scholar]
  6. GebrieA. AlebelA. ZegeyeA. TesfayeB. WagnewF. Prevalence and associated factors of active trachoma among children in Ethiopia: A systematic review and meta-analysis.BMC Infect. Dis.2019191107310.1186/s12879‑019‑4686‑8 31864307
     [Google Scholar]
  7. HadfieldJ. HarrisS.R. Seth-SmithH.M.B. ParmarS. AnderssonP. GiffardP.M. SchachterJ. MoncadaJ. EllisonL. VauletM.L.G. FermepinM.R. RadebeF. MendozaS. OuburgS. MorréS.A. SachseK. PuolakkainenM. KorhonenS.J. SonnexC. WigginsR. JalalH. BrunelliT. CaspriniP. PittR. IsonC. SavichevaA. ShipitsynaE. HadadR. KariL. BurtonM.J. MabeyD. SolomonA.W. LewisD. MarshP. UnemoM. ClarkeI.N. ParkhillJ. ThomsonN.R. Comprehensive global genome dynamics of Chlamydia trachomatis show ancient diversification followed by contemporary mixing and recent lineage expansion.Genome Res.20172771220122910.1101/gr.212647.116 28588068
     [Google Scholar]
  8. TanwarP. NaagarM. MaityM.K. A review on trachoma: Etiology, epidemiology, pathophysiology, differential diagnosis, clinical management and treatment modalities.Int. J. Pharma Sci.202429118
     [Google Scholar]
  9. GarciaH.H. Del BruttoO.H. Neurocysticercosis: Updated concepts about an old disease.Lancet Neurol.200541065366110.1016/S1474‑4422(05)70194‑0
     [Google Scholar]
  10. RaffaldiI. ScolfaroC. MignoneF. AguzziS. DenegriF. TovoP.A. An uncommon cause of seizures in children living in developed countries: Neurocysticercosis -A case report.Ital. J. Pediatr.2011371910.1186/1824‑7288‑37‑9 21266080
     [Google Scholar]
  11. WrightH.R. TurnerA. TaylorH.R. Trachoma.Lancet200837196281945195410.1016/S0140‑6736(08)60836‑3 18539226
     [Google Scholar]
  12. HuV.H. Harding-EschE.M. BurtonM.J. BaileyR.L. KadimpeulJ. MabeyD.C.W. Epidemiology and control of trachoma: Systematic review.Trop. Med. Int. Health201015667369110.1111/j.1365‑3156.2010.02521.x 20374566
     [Google Scholar]
  13. ThyleforsB. DawsonC.R. JonesB.R. WestS.K. TaylorH.R. A simple system for the assessment of trachoma and its complications.Bull. World Health Organ.1987654477483 3500800
     [Google Scholar]
  14. BhosaiS.J. BaileyR.L. GaynorB.D. LietmanT.M. Trachoma.Curr. Opin. Ophthalmol.201223428829510.1097/ICU.0b013e32835438fc 22569465
     [Google Scholar]
  15. Abu el-AsrarA.M. GeboesK. MissottenL. Immunology of trachomatous conjunctivitis.Bull. Soc. Belge Ophtalmol.20012807396 11486468
     [Google Scholar]
  16. TakayanaguiO.M. OdashimaN.S. Clinical aspects of neurocysticercosis.Parasitol. Int.200655Suppl.S111S11510.1016/j.parint.2005.11.016 16330240
     [Google Scholar]
  17. NikolićS. StevanovićG. Neurocysticercosis-pathogenesis and clinical aspects Srp. Arh. Celok. Lek.20061345-6246250 16972416
     [Google Scholar]
  18. GibbonsS. An overview of plant extracts as potential therapeutics.Expert Opin. Ther. Patents.200313448949710.1517/13543776.13.4.489
     [Google Scholar]
  19. AnaM.L. Biological potential and medical use of secondary metabolites.Medicines201966610.3390/medicines6020066 31212776
     [Google Scholar]
  20. BoullataJ.I. NaceA.M. Safety issues with herbal medicine.Pharmacotherapy200020325726910.1592/phco.20.4.257.34886 10730682
     [Google Scholar]
  21. PotrozM. ChoN.J. Natural products for the treatment of trachoma and Chlamydia trachomatis.Molecules20152034180420310.3390/molecules20034180 25751782
     [Google Scholar]
  22. Del BruttoO.H. Neurocysticercosis.Handb. Clin. Neurol.20141211445145910.1016/B978‑0‑7020‑4088‑7.00097‑3 24365429
     [Google Scholar]
  23. NewmanD.J. CraggG.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010.J. Nat. Prod.201275331133510.1021/np200906s 22316239
     [Google Scholar]
  24. AbubakarY. EgbunaC. OlatundeA. TijjaniH. OdohU. Medicinal plants and phytochemicals effective against Chlamydia trachomatis.In: Neglected tropical diseases and phytochemicals in drug discovery; Wiley online Library2021
     [Google Scholar]
  25. SantoshT.N. RajeshG.S. NarayanN.P. AnilG.S. SandipM.A. NutanB. Herbal drugs in the management of Trachoma.Int. J. Res. Publ. Rev.202451140114015
     [Google Scholar]
  26. McMurryJ.E. Organic chemistry with biological applications. Secondary Metabolites: An Introduction to Natural Products Chemistry.Stamford, USACengage Learning Ltd201510161046
     [Google Scholar]
  27. AmirF. YamW.S. KoayY.C. Phytochemical constituents and biological activities of Erythrina indica.Eur. J. Chem.201131456156510.5155/eurjchem.2.4.561‑565.455
     [Google Scholar]
  28. KaushalA. SharmaM. SharmaN. Ethnomedicinal, phytochemical, therapeutic and pharmacological review of the genus Erythrina.Int. J. Bot. Stud.202056642648
     [Google Scholar]
  29. FahmyN.M. Al-SayedE. El-ShazlyM. SingabA.N. Comprehensive review on flavonoids biological activities of Erythrina plant species.Ind. Crops Prod.201812350053810.1016/j.indcrop.2018.06.028
     [Google Scholar]
  30. MahadyG.B. ChadwickL.R. Goldenseal (Hydrastis canadensis): Is there enough scientific evidence to support safety and efficacy?Nutr. Clin. Care20014524324910.1046/j.1523‑5408.2001.00004.x
     [Google Scholar]
  31. PillaiM.G. KumarA. SharmaR. BhasinN. LC–MS based workflows for qualitative and quantitative analysis for homeopathic preparation of Hydrastis canadensis.Chromatogr.2013771119131
     [Google Scholar]
  32. ChignellC.F. SikR.H. WatsonM.A. WielgusA.R. Photochemistry and photocytotoxicity of alkaloids from Goldenseal (Hydrastis canadensis L.) 3: effect on human lens and retinal pigment epithelial cells.Photochem. Photobiol.200783493894310.1111/j.1751‑1097.2007.00086.x 17645667
     [Google Scholar]
  33. TimothyC. BirdsallN.D. GregoryS. KellyN.D. Berberine: Therapeutic potential of an alkaloid found in several medicinal plants.Altern. Med. Rev.19972294103
     [Google Scholar]
  34. MohanM. PantC.R. AngraS.K. MahajanV.M. Berberine in trachoma (A clinical trial).Indian J. Ophthalmol.19823026975 6754599
     [Google Scholar]
  35. DahhamS.S. Al-RawiS.S. IbrahimA.H. Abdul MajidA.S. Abdul MajidA.M.S. Antioxidant, anticancer, apoptosis properties and chemical composition of black truffle Terfeziaclaveryi.Saudi J. Biol. Sci.201825815241534
     [Google Scholar]
  36. Marqués-GálvezJ.E. MorteA. Navarro-RódenasA. García-CarmonaF. Pérez-GilabertM. Purification and characterization of Terfezia claveryi TcCAT-1, a desert truffle catalase upregulated in mycorrhizal symbiosis.PLoS One2019147e021930010.1371/journal.pone.0219300 31291312
     [Google Scholar]
  37. MandeelQ.A. Al-LaithA.A.A. Ethnomycological aspects of the desert truffle among native Bahraini and non-Bahraini peoples of the Kingdom of Bahrain.J. Ethnopharmacol.2007110111812910.1016/j.jep.2006.09.014 17049427
     [Google Scholar]
  38. FaragM.A. FathiD. ShammaS. ShawkatM.S.A. ShalabiS.M. SeediH.R.E. AfifiS.M. Comparative metabolome classification of desert truffles Terfeziaclaveryi and terfeziaboudieri via its aroma and nutrients profile.Saudi J. Biol. Sci.20222911103462 36267911
     [Google Scholar]
  39. KhojahM.J. Antimicrobial efficacy of extracts of Saudi Arabian desert Terfeziaclaveryi truffles.Saudi J. Biol. Sci.2022291110346210.1016/j.sjbs.2022.103462 36267911
     [Google Scholar]
  40. SaadabiA.M. AlhussainiM.S. HashimK. GhanayemA.A.A. Efficacy of the desert truffle Terfeziaclaveryi to cure trachoma disease with special emphasis on its antibacterial bioactivity.Trends Med. Res.2016111283410.3923/tmr.2016.28.34
     [Google Scholar]
  41. UmerS. TekeweA. KebedeN. Antidiarrhoeal and antimicrobial activity of Calpurnia aurea leaf extract.BMC Complement. Altern. Med.20131312110.1186/1472‑6882‑13‑21 23351272
     [Google Scholar]
  42. SharanyaM. SuganyaJ. MahendranR. PoornimaV. Targeting Omc-B of Chlamydia trachomatis for the Blinding Infection Trachoma using Phytochemicals from Calpurnia aurea and Abrus precatorius.Res. J. Pharm. Technol.20191252396240310.5958/0974‑360X.2019.00401.3
     [Google Scholar]
  43. CosaS. RakomaJ.R. YusufA.A. Calpurnia aurea (Aiton) benth extracts reduce quorum sensing controlled virulence factors in Pseudomonas aeruginosa.Molecules20202510228310.3390/molecules25102283
     [Google Scholar]
  44. PotdarD. HirwaniR.R. DhulapS. Phyto-chemical and pharmacological applications of Berberis aristata.Fitoterapia2012835817830
     [Google Scholar]
  45. MalhotraB. KulkarniG.T. DhimanN. JoshiD.D. ChanderS. KharkwalA. Recent advances on Berberisaristata emphasizing berberine alkaloid including phytochemistry, pharmacology and drug delivery system.J. Herb. Med.202127100433
     [Google Scholar]
  46. ChanderV. AswalJ.S. DobhalR. UniyalD.P. A review on pharmacological potential of Berberine; An active component of Himalayan Berberis aristata.J Phytopharm20172565358
     [Google Scholar]
  47. KhoslaP.K. NeerajV.I. GuptaS.K. SatpathyG. Berberine, a potential drug for trachoma.Rev. Int. Trach. Pathol. Ocul. Trop. Subtrop. Sante Publique199269147165 1344968
     [Google Scholar]
  48. WangM.W. HaoX. ChenK. Biological screening of natural products and drug innovation in China.Philos. Trans. R. Soc. Lond. B Biol. Sci.200736214821093110510.1098/rstb.2007.2036 17317643
     [Google Scholar]
  49. Robert MusiolR. MalarzK. MularskiJ. Quinoline alkaloids against neglected tropical diseases.Curr. Org. Chem.2017211818961906
     [Google Scholar]
  50. HadiM.Y. HameedI.H. IbraheamI.A. Mentha pulegium: Medicinal uses, anti-hepatic, antibacterial, antioxidant effect and analysis of bioactive natural compounds: A review.Res. J. Pharm. Technol.201710103580358410.5958/0974‑360X.2017.00648.5
     [Google Scholar]
  51. SinghS. PathakN. FatimaE. NegiA.S. Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine.Eur. J. Med. Chem.202122622611383910.1016/j.ejmech.2021.113839 34536668
     [Google Scholar]
  52. HuangZ.J. ZengY. LanP. SunP.H. ChenW.M. Advances in structural modifications and biological activities of berberine: An active compound in traditional Chinese medicine.Mini Rev. Med. Chem.201111131122112910.2174/138955711797655362 22353221
     [Google Scholar]
  53. ShangX.F. YangC.J. Morris-NatschkeS.L. LiJ.C. YinX.D. LiuY.Q. GuoX. PengJ.W. GotoM. ZhangJ.Y. LeeK.H. Biologically active isoquinoline alkaloids covering 2014–2018.Med. Res. Rev.20204062212228910.1002/med.21703 32729169
     [Google Scholar]
  54. KongY. LiL. ZhaoL.G. YuP. LiD.D. A patent review of berberine and its derivatives with various pharmacological activities (2016-2020).Expert Opin. Ther. Pat.2022322211223
     [Google Scholar]
  55. PlazasE. AvilaM. M.C.; Muñoz, D.R.; Cuca S, L.E. Natural isoquinoline alkaloids: Pharmacological features and multi-target potential for complex diseases.Pharmacol. Res.202217710612610.1016/j.phrs.2022.106126 35151857
     [Google Scholar]
  56. PlazasE. HagenowS. Avila MurilloM. StarkH. CucaL.E. Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and Aβ1-42 aggregation.Bioorg. Chem.20209810372210.1016/j.bioorg.2020.103722 32155491
     [Google Scholar]
/content/journals/cbc/10.2174/0115734072351741250318232624
Loading
Insights of Natural Isoquinoline Alkaloids in the Management of Trachoma
Curr. Bioact. Compd. 22, e15734072351741 (2026); https://doi.org/10.2174/0115734072351741250318232624
/content/journals/cbc/10.2174/0115734072351741250318232624
/content/journals/cbc/10.2174/0115734072351741250318232624
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): health infestation; isoquinoline alkaloids; Neglected tropical diseases; ocular infection; secondary metabolites; trachoma

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test